UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction of knee trajectory based on surface electromyogram with independent component analysis combined with support vector regression

International journal of advanced robotic systems, 2022-07, Vol.19 (4), p.172988062211196

2022

Volltextzugriff (PDF)

Cross-cultural modifications and measurement properties of the CHAMPS questionnaire among Chinese older adults

Journal of exercise science and fitness, 2021-01, Vol.19 (1), p.13-18

2021

Volltextzugriff (PDF)

Effect of tap dance on plantar pressure, postural stability and lower body function in older patients at risk of diabetic foot: a randomized controlled trial

BMJ open diabetes research & care, 2021-03, Vol.9 (1), p.e001909

2021

Volltextzugriff (PDF)

Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice

The FASEB journal, 2019-09, Vol.33 (9), p.10425-10442

2019

Volltextzugriff (PDF)

sEMG-Based Lower Limb Motion Prediction Using CNN-LSTM with Improved PCA Optimization Algorithm

Journal of bionics engineering, 2023-03, Vol.20 (2), p.612-627

2023

Volltextzugriff (PDF)

Melatonin attenuates repeated mild traumatic brain injury-induced cognitive deficits by inhibiting astrocyte reactivation

Biochemical and biophysical research communications, 2021-11, Vol.580, p.20-27

2021

Volltextzugriff (PDF)

Synergistic effect of tanshinone IIA and mesenchymal stem cells on preventing learning and memory deficits via anti-apoptosis, attenuating tau phosphorylation and enhancing the activity of central cholinergic system in vascular dementia

Neuroscience letters, 2017-01, Vol.637, p.175-181

2017

Volltextzugriff (PDF)

Chrysin ameliorates hepatic steatosis induced by a diet deficient in methionine and choline by inducing the secretion of hepatocyte nuclear factor 4α‐dependent very low‐density lipoprotein

Journal of biochemical and molecular toxicology, 2020-07, Vol.34 (7), p.e22497-n/a

2020

Volltextzugriff (PDF)

The study of BMW M3 and Chevrolet Cavalier's dynamics performance

2021 2nd International Conference on Intelligent Design (ICID), 2021, p.72-78

2021

Volltextzugriff (PDF)

COVID-19 and gastrointestinal symptoms

British journal of surgery, 2020-09, Vol.107 (10), p.e382-e383

2020

Volltextzugriff (PDF)

Corrigendum to: COVID-19 and gastrointestinal symptoms

British journal of surgery, 2021-05

2021

Volltextzugriff (PDF)

Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial

Haematologica (Roma), 2024-09

2024

Volltextzugriff (PDF)

A Phase Ib Open-Label Study of MRG001 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Blood, 2023-11, Vol.142 (Supplement 1), p.3089-3089

2023

Volltextzugriff (PDF)

An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma

Combinatorial chemistry & high throughput screening, 2022-01, Vol.25 (13), p.2203-2216

2022

Volltextzugriff (PDF)

Orientin Promotes Antioxidant Capacity, Mitochondrial Biogenesis, and Fiber Transformation in Skeletal Muscles through the AMPK Pathway

Journal of agricultural and food chemistry, 2024-03, Vol.72 (12), p.6226-6235

2024

Volltextzugriff (PDF)

Efficacy and safety of orelabrutinib in diffuse large B-cell lymphoma: A real-world analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e19556-e19556

2022

Volltextzugriff (PDF)

XPO1 Inhibitor (ATG-010) Plus GemOx Regimen for Heavily Pretreated Patients with Relapsed or Refractory (R/R) T and NK-Cell Lymphoma：Updates of the Phase Ib Touch Study

Blood, 2022-11, Vol.140 (Supplement 1), p.6554-6555

2022

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Efficacy of Acalabrutinib in Chinese Patients with Relapsed/Refractory Mantle Cell Lymphoma and Other B-Cell Malignancies: An Open-Label, Multicenter Phase 1/2 Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.6496-6497

2022

Volltextzugriff (PDF)

The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial

Clinical cancer research, 2023-04, Vol.29 (8), p.1440-1449

2023

Volltextzugriff (PDF)

Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphoma

Leukemia & lymphoma, 2024-04, Vol.65 (5), p.1-652

2024

Volltextzugriff (PDF)

Phase 2 Study of Golidocitinib, a JAK1 Selective Inhibitor, As Maintenance Therapy in Patients with Peripheral T Cell Lymphomas after First-Line Systemic Therapy (JACKPOT26)

Blood, 2023-11, Vol.142 (Supplement 1), p.4430-4430

2023

Volltextzugriff (PDF)

XPO1 Inhibitor (ATG-010) Plus Chemotherapy per Investigator's Choice for Heavily Pretreated Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Extranodal NK/T-Cell Lymphoma (ENKTL)：Preliminary Results from a Multicenter, Single-Arm, Phase Ib Study (TOUCH Trial)

Blood, 2021-11, Vol.138 (Supplement 1), p.2452-2452

2021

Volltextzugriff (PDF)

A phase 1 study evaluating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of Bcl-2 inhibitor BGB-11417 in adult patients with mature B-cell malignancies

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7558-7558

2023

Volltextzugriff (PDF)

A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Bcl-2 Inhibitor Bgb-11417 in Adult Patients with Mature B-Cell Malignancies: Preliminary Data

Blood, 2022-11, Vol.140 (Supplement 1), p.6717-6718

2022

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(43)
Tagungsberichte
(1)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(12)
Animals
(6)
Humans
(5)
Male
(5)
Mice
(5)
Biochemistry & Molecular Biology
(4)
Disease Models, Animal
(3)
Physical Sciences
(3)
Treatment Outcome
(3)
Algorithms
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Cancer
(2)
Cell Biology
(2)
Chemistry
(2)
Chemistry, Applied
(2)
Chemotherapy
(2)
Diabetes
(2)
Endocrinology & Metabolism
(2)
Exercise
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prediction of knee trajectory based on surface electromyogram with independent component analysis combined with support vector regression

Cross-cultural modifications and measurement properties of the CHAMPS questionnaire among Chinese older adults

Effect of tap dance on plantar pressure, postural stability and lower body function in older patients at risk of diabetic foot: a randomized controlled trial

Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice

sEMG-Based Lower Limb Motion Prediction Using CNN-LSTM with Improved PCA Optimization Algorithm

Melatonin attenuates repeated mild traumatic brain injury-induced cognitive deficits by inhibiting astrocyte reactivation

Synergistic effect of tanshinone IIA and mesenchymal stem cells on preventing learning and memory deficits via anti-apoptosis, attenuating tau phosphorylation and enhancing the activity of central cholinergic system in vascular dementia

Chrysin ameliorates hepatic steatosis induced by a diet deficient in methionine and choline by inducing the secretion of hepatocyte nuclear factor 4α‐dependent very low‐density lipoprotein

The study of BMW M3 and Chevrolet Cavalier's dynamics performance

COVID-19 and gastrointestinal symptoms

Corrigendum to: COVID-19 and gastrointestinal symptoms

Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial

A Phase Ib Open-Label Study of MRG001 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma

Orientin Promotes Antioxidant Capacity, Mitochondrial Biogenesis, and Fiber Transformation in Skeletal Muscles through the AMPK Pathway

Efficacy and safety of orelabrutinib in diffuse large B-cell lymphoma: A real-world analysis

XPO1 Inhibitor (ATG-010) Plus GemOx Regimen for Heavily Pretreated Patients with Relapsed or Refractory (R/R) T and NK-Cell Lymphoma：Updates of the Phase Ib Touch Study

Pharmacokinetics, Safety, and Efficacy of Acalabrutinib in Chinese Patients with Relapsed/Refractory Mantle Cell Lymphoma and Other B-Cell Malignancies: An Open-Label, Multicenter Phase 1/2 Trial

The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial

Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphoma

Phase 2 Study of Golidocitinib, a JAK1 Selective Inhibitor, As Maintenance Therapy in Patients with Peripheral T Cell Lymphomas after First-Line Systemic Therapy (JACKPOT26)

XPO1 Inhibitor (ATG-010) Plus Chemotherapy per Investigator's Choice for Heavily Pretreated Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) and Extranodal NK/T-Cell Lymphoma (ENKTL)：Preliminary Results from a Multicenter, Single-Arm, Phase Ib Study (TOUCH Trial)

A phase 1 study evaluating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of Bcl-2 inhibitor BGB-11417 in adult patients with mature B-cell malignancies

A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Bcl-2 Inhibitor Bgb-11417 in Adult Patients with Mature B-Cell Malignancies: Preliminary Data

Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study

Suchergebnisse filtern